Related Experiment Video
Updated: May 14, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Oleanolic acid and ursolic acid: novel hepatitis C virus antivirals that inhibit NS5B activity
Lingbao Kong1, Shanshan Li, Qingjiao Liao
1College of Bioscience and Engineering, Jiangxi Agricultural University, Nanchang, Jiangxi 330045, China. lingbaok@hotmail.com
Abstract:
Hepatitis C virus (HCV) infects up to 170 million people worldwide and causes significant morbidity and mortality. Unfortunately, current therapy is only curative in approximately 50% of HCV patients and has adverse side effects, which warrants the need to develop novel and effective antivirals against HCV. We have previously reported that the Chinese herb Fructus Ligustri Lucidi (FLL) directly inhibited HCV NS5B RNA-dependent RNA polymerase (RdRp) activity (Kong et al., 2007). In this study, we found that the FLL aqueous extract strongly suppressed HCV replication. Further high-performance liquid chromatography (HPLC) analysis combined with inhibitory assays indicates that oleanolic acid and ursolic acid are two antiviral components within FLL aqueous extract that significantly suppressed the replication of HCV genotype 1b replicon and HCV genotype 2a JFH1 virus. Moreover, oleanolic acid and ursolic acid exhibited anti-HCV activity at least partly through suppressing HCV NS5B RdRp activity as noncompetitive inhibitors. Therefore, our results for the first time demonstrated that natural products oleanolic acid and ursolic acid could be used as potential HCV antivirals that can be applied to clinic trials either as monotherapy or in combination with other HCV antivirals.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Inhibitors of Bacterial DNA Synthesis
Viral Hepatitis I: Introduction
Inhibitors of Bacterial Protein Synthesis
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

